Agile Surgical Assistants LLC.
Avalyn Pharma Inc.
AZTherapies, Inc.

Azuba Corporation
Customer Evolution
Cybervore, Inc.
CytoDyn Inc (OTC: CYDY)
Cytokinetics, Incorporated
data245
E25Bio, Inc.
Edafio Technology Partners
EffortlessHR®
Ensite Vascular, LLC.
Etiometry Inc.
ExpressCells
Eyedaptic, Inc.
Folium Biosciences
GA International Inc.
HealthLynked (OTC:HLYK)
Health Scholars
Helius Medical Technologies, Inc.
Imago BioSciences, Inc.
iMedrix Inc.
InteropX
Machavert Pharmaceuticals
MetVital, Inc.
Onconova
Ospitek, Inc.
PCT LTD (OTC:PINK “PCTL”)
Precigen, Inc.
(Nasdaq: PGEN)
SanMelix Laboratories, Inc.
Siani
SpinalCyte,LLC
Tipping Point Solutions
ZQedge Corp.

E25Bio has developed and preparing to bring to market a Paper-based Lateral Flow Antigen Test Strip for Detecting Active COVID-19 Infection faster, simpler and cheaper than today’s Gold Standard

E25Bio, Inc.

Bobby Brooke Herrera, PhD, Co-founder and CEO

www.e25bio.com
Print - PDF  Mobile - PDF


___________________________________________________________________________________

ExpressCells: Genetically-Engineered Cell Lines to Support Better Science

ExpressCells

Matthew Handel,
Chief Executive Officer

www.xpresscells.com

Print - PDF Mobile - PDF

_____________________________________________________________________________________

A Human Energy Metabolite is Hopeful for Age-Related Chronic Diseases

MetVital, Inc.

Alan Cash, President & CEO

www.metvital.com

Print - PDF  Mobile - PDF

__________________________________________________________________________


Using Augmented Reality Visual Aids with Proprietary Software, Eyedaptic, Inc. is optimizing and enhancing Peripheral Vision for people with Macular Degeneration or Loss of Central Vision

Eyedaptic, Inc.

Jay Cormier, Founder, President & CEO

www.eyedaptic.com
Print - PDF  Mobile - PDF

_________________________________________________________________________

Isopure is Designing, Redesigning and adding Computerization to Medical Devices for End Stage Renal Failure that Reduce or Eliminate Human Intervention

Isopure Corp

Kevin Gillespie, President & CEO
www.isopure.com

Print - PDF  Mobile - PDF


__________________________________________________________________________


New class of Cancer Therapeutics, RAL GTPase Inhibitors show potential to Inhibit Tumor Growth and Metastasis in KRAS Mutant Cancers that Represent 30% of All Cancers

Machavert Pharmaceuticals

Dr. Jakub Staszak-Jirkovsky, Co-Founder & CEO

www.machavert.com

Print - PDF  Mobile - PDF

__________________________________________________________________________


 Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression

AZTherapies, Inc.

David R Elmaleh, Ph.D., Founder & CEO

www.aztherapies.com

Print Version - PDF  Mobile Download - PDF

___________________________________________________________________________


SpinalCyte chooses Fibroblasts over Stem Cells for Regenerative Medicine

SpinalCyte,LLC

Pete O'Heeron, Chief Executive Officer

www.spinalcyte.com

Print Version - PDF  Mobile Download - PDF


________________________________________________________________________

Machine Learning and the Evolution of Employee Benefits

data245

Paul J Burt, Founder

https://www.data245.com/contactform

Print Version - PDF  Mobile Download - PDF